AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis
Bryna S.M. Chow(Florey Institute of Neuroscience and Mental Health), Chrishan S. Samuel(Discovery Institute)
Cited by 49
Related Papers
Relaxin Signals through a RXFP1-pERK-nNOS-NO-cGMP-Dependent Pathway to Up-Regulate Matrix Metalloproteinases: The Additional Involvement of iNOS
|PLoS ONE|2012|129
Relaxin Regulates Myofibroblast Contractility and Protects against Lung Fibrosis
|American Journal Of Pathology|2011|94
Antifibrotic Properties of Relaxin: In Vivo Mechanism of Action in Experimental Renal Tubulointerstitial Fibrosis
|Endocrinology|2010|72
ML290 is a biased allosteric agonist at the relaxin receptor RXFP1
|Scientific Reports|2017|62